Our top pick for
DarioHealth Corp is a diagnostics & research business based in the US. DarioHealth shares (DRIO) are listed on the NASDAQ and all prices are listed in US Dollars. DarioHealth employs 62 staff and has a trailing 12-month revenue of around USD$7.3 million.
|52-week range||USD$3.02 - USD$22.4899|
|50-day moving average||USD$12.5259|
|200-day moving average||USD$12.4688|
|Wall St. target price||USD$16.32|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.576|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$7.3 million|
|Gross profit TTM||USD$2.6 million|
|Return on assets TTM||-62.87%|
|Return on equity TTM||-126.45%|
|Market capitalisation||USD$106.9 million|
TTM: trailing 12 months
There are currently 118,322 DarioHealth shares held short by investors – that's known as DarioHealth's "short interest". This figure is 0.2% down from 118,579 last month.
There are a few different ways that this level of interest in shorting DarioHealth shares can be evaluated.
DarioHealth's "short interest ratio" (SIR) is the quantity of DarioHealth shares currently shorted divided by the average quantity of DarioHealth shares traded daily (recently around 90322.13740458). DarioHealth's SIR currently stands at 1.31. In other words for every 100,000 DarioHealth shares traded daily on the market, roughly 1310 shares are currently held short.
However DarioHealth's short interest can also be evaluated against the total number of DarioHealth shares, or, against the total number of tradable DarioHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case DarioHealth's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 DarioHealth shares in existence, roughly 10 shares are currently held short) or 0.0204% of the tradable shares (for every 100,000 tradable DarioHealth shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against DarioHealth.
Find out more about how you can short DarioHealth stock.
We're not expecting DarioHealth to pay a dividend over the next 12 months.
DarioHealth's shares were split on a 1:18 basis on 4 March 2016. So if you had owned 18 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DarioHealth shares – just the quantity. However, indirectly, the new 1700% higher share price could have impacted the market appetite for DarioHealth shares which in turn could have impacted DarioHealth's share price.
Over the last 12 months, DarioHealth's shares have ranged in value from as little as $3.02 up to $22.4899. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DarioHealth's is 1.2667. This would suggest that DarioHealth's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
DarioHealth Corp., a digital health company, develops and commercializes patented and proprietary technologies providing consumers with laboratory-testing capabilities using smart phones and other mobile devices in the United States, Europe, Australia, and Canada. The company's flagship product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with Dario Blood Glucose Monitoring System, a pocket-sized, blood glucose monitoring device. It offers DarioEngage software platform, where the company digitally engages with Dario users and assists them in monitoring their chronic illnesses, as well as provides them with coaching, support, digital communications; and real time alerts, trends, and pattern analysis. DarioHealth Corp. markets its products directly to consumer cash sales, as well as retail pharmacy, hospitals, and distributors; and through online. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is headquartered in Caesarea, Israel.
Steps to owning and managing CYBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing CHCI, with 24-hour and historical pricing before you buy.
Steps to owning and managing CIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing CKX, with 24-hour and historical pricing before you buy.
Steps to owning and managing CHA, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTHR, with 24-hour and historical pricing before you buy.
Steps to owning and managing CNBKA, with 24-hour and historical pricing before you buy.
Steps to owning and managing CATM, with 24-hour and historical pricing before you buy.
Steps to owning and managing CRME, with 24-hour and historical pricing before you buy.
Steps to owning and managing TECH, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.